These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended March 31, 2014
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Transition Period from to
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
Item
|
Page
|
|
|
|
|
|
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
|
|
(in thousands of dollars, except
par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
532,643
|
|
|
$
|
461,301
|
|
Marketable securities
|
|
243,694
|
|
|
239,388
|
|
||
Accounts receivable, net
|
|
421,879
|
|
|
428,457
|
|
||
Inventories
|
|
439,009
|
|
|
471,879
|
|
||
Prepaid expenses and other current assets
|
|
15,880
|
|
|
13,888
|
|
||
Deferred income taxes
|
|
34,158
|
|
|
34,169
|
|
||
Total current assets
|
|
1,687,263
|
|
|
1,649,082
|
|
||
Property, plant and equipment, net
|
|
2,150,643
|
|
|
2,088,014
|
|
||
Equity investments
|
|
67,560
|
|
|
66,875
|
|
||
Other assets, net
|
|
|
|
|
|
|
||
Intangible assets, net
|
|
157,086
|
|
|
159,046
|
|
||
Deferred charges and other assets, net
|
|
109,404
|
|
|
97,892
|
|
||
Total other assets, net
|
|
266,490
|
|
|
256,938
|
|
||
Total assets
|
|
$
|
4,171,956
|
|
|
$
|
4,060,909
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable
|
|
$
|
211,952
|
|
|
$
|
249,613
|
|
Accrued liabilities
|
|
147,982
|
|
|
155,245
|
|
||
Total current liabilities
|
|
359,934
|
|
|
404,858
|
|
||
Long-term debt
|
|
763,909
|
|
|
763,879
|
|
||
Deferred income taxes
|
|
447,203
|
|
|
437,976
|
|
||
Other liabilities
|
|
32,338
|
|
|
35,593
|
|
||
Total liabilities
|
|
1,603,384
|
|
|
1,642,306
|
|
||
Commitments and contingencies (Notes 7 and 15)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized;
no shares issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 150,000,000 shares authorized;
134,682,004 and 134,580,208 shares issued at March 31, 2014
and December 31, 2013, respectively (Note 1)
|
|
1,347
|
|
|
1,346
|
|
||
Common stock, held in treasury, at cost; 1,252,922 shares
at March 31, 2014 and December 31, 2013 (Note 1)
|
|
(46,220
|
)
|
|
(46,220
|
)
|
||
Additional paid-in capital
|
|
519,323
|
|
|
511,432
|
|
||
Retained earnings
|
|
2,095,904
|
|
|
1,954,661
|
|
||
Accumulated other comprehensive loss
|
|
(1,782
|
)
|
|
(2,616
|
)
|
||
Total stockholders' equity
|
|
2,568,572
|
|
|
2,418,603
|
|
||
Total liabilities and stockholders' equity
|
|
$
|
4,171,956
|
|
|
$
|
4,060,909
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in thousands of dollars, except per share data and share amounts)
|
||||||
Net sales
|
|
$
|
1,027,676
|
|
|
$
|
864,647
|
|
Cost of sales
|
|
740,666
|
|
|
636,838
|
|
||
Gross profit
|
|
287,010
|
|
|
227,809
|
|
||
Selling, general and administrative expenses
|
|
38,955
|
|
|
33,754
|
|
||
Income from operations
|
|
248,055
|
|
|
194,055
|
|
||
Other income (expense)
|
|
|
|
|
||||
Interest expense
|
|
(9,157
|
)
|
|
(6,281
|
)
|
||
Other income, net
|
|
2,509
|
|
|
3,519
|
|
||
Income before income taxes
|
|
241,407
|
|
|
191,293
|
|
||
Provision for income taxes
|
|
83,375
|
|
|
67,946
|
|
||
Net income
|
|
$
|
158,032
|
|
|
$
|
123,347
|
|
Earnings per share (Note 1):
|
|
|
|
|
||||
Basic
|
|
$
|
1.18
|
|
|
$
|
0.92
|
|
Diluted
|
|
$
|
1.18
|
|
|
$
|
0.92
|
|
Weighted average shares outstanding (Note 1):
|
|
|
|
|
||||
Basic
|
|
133,072,254
|
|
|
133,251,071
|
|
||
Diluted
|
|
133,612,924
|
|
|
133,817,737
|
|
||
Dividends per common share (Note 1)
|
|
$
|
0.1260
|
|
|
$
|
0.0938
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in thousands of dollars)
|
||||||
Net income
|
|
$
|
158,032
|
|
|
$
|
123,347
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
||||
Pension and other post-retirement benefits liability
|
|
|
|
|
||||
Amortization of benefits liability
|
|
219
|
|
|
614
|
|
||
Income tax provision on pension and other post-retirement benefits liability
|
|
(84
|
)
|
|
(236
|
)
|
||
Foreign currency translation adjustments
|
|
(898
|
)
|
|
(570
|
)
|
||
Available-for-sale investments
|
|
|
|
|
||||
Unrealized holding gains on investments
|
|
2,467
|
|
|
—
|
|
||
Reclassification of net realized loss to net income
|
|
25
|
|
|
—
|
|
||
Income tax provision on available-for-sale investments
|
|
(895
|
)
|
|
—
|
|
||
Other comprehensive income (loss)
|
|
834
|
|
|
(192
|
)
|
||
Comprehensive income
|
|
$
|
158,866
|
|
|
$
|
123,155
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in thousands of dollars)
|
||||||
Cash flows from operating activities
|
|
|
|
|
||||
Net income
|
|
$
|
158,032
|
|
|
$
|
123,347
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
||||
Depreciation and amortization
|
|
45,972
|
|
|
35,356
|
|
||
(Recovery of) provision for doubtful accounts
|
|
(144
|
)
|
|
393
|
|
||
Amortization of debt issuance costs
|
|
365
|
|
|
365
|
|
||
Stock-based compensation expense
|
|
2,222
|
|
|
1,499
|
|
||
Loss from disposition of fixed assets
|
|
855
|
|
|
2,387
|
|
||
Deferred income taxes
|
|
8,275
|
|
|
29,466
|
|
||
Windfall tax benefits from share-based payment arrangements
|
|
(3,512
|
)
|
|
(3,844
|
)
|
||
Income from equity method investments, net of dividends
|
|
(685
|
)
|
|
(178
|
)
|
||
Other loss, net
|
|
444
|
|
|
—
|
|
||
Changes in operating assets and liabilities
|
|
|
|
|
||||
Accounts receivable
|
|
5,332
|
|
|
(7,917
|
)
|
||
Inventories
|
|
32,870
|
|
|
(8,776
|
)
|
||
Prepaid expenses and other current assets
|
|
(1,478
|
)
|
|
(2,077
|
)
|
||
Accounts payable
|
|
(29,706
|
)
|
|
14,733
|
|
||
Accrued liabilities
|
|
(4,952
|
)
|
|
(14,670
|
)
|
||
Other, net
|
|
(1,385
|
)
|
|
(53,832
|
)
|
||
Net cash provided by operating activities
|
|
212,505
|
|
|
116,252
|
|
||
Cash flows from investing activities
|
|
|
|
|
||||
Additions to property, plant and equipment
|
|
(110,741
|
)
|
|
(150,784
|
)
|
||
Proceeds from disposition of assets
|
|
12
|
|
|
2
|
|
||
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
167
|
|
||
Proceeds from sales and maturities of securities
|
|
30,119
|
|
|
124,873
|
|
||
Purchase of securities
|
|
(49,025
|
)
|
|
(94,903
|
)
|
||
Settlements of derivative instruments
|
|
(409
|
)
|
|
(679
|
)
|
||
Net cash used for investing activities
|
|
(130,044
|
)
|
|
(121,324
|
)
|
||
Cash flows from financing activities
|
|
|
|
|
||||
Dividends paid
|
|
(16,789
|
)
|
|
(12,553
|
)
|
||
Proceeds from exercise of stock options
|
|
2,158
|
|
|
1,590
|
|
||
Windfall tax benefits from share-based payment arrangements
|
|
3,512
|
|
|
3,844
|
|
||
Net cash used for financing activities
|
|
(11,119
|
)
|
|
(7,119
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
|
71,342
|
|
|
(12,191
|
)
|
||
Cash and cash equivalents at beginning of period
|
|
461,301
|
|
|
790,078
|
|
||
Cash and cash equivalents at end of period
|
|
$
|
532,643
|
|
|
$
|
777,887
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
Current
|
$
|
243,694
|
|
|
$
|
239,388
|
|
Non-current
|
17,195
|
|
|
—
|
|
||
Total available-for-sale securities
|
$
|
260,889
|
|
|
$
|
239,388
|
|
|
|
March 31, 2014
|
||||||||||||||
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
Corporate bonds
|
|
$
|
116,669
|
|
|
$
|
470
|
|
|
$
|
(41
|
)
|
|
$
|
117,098
|
|
U.S. government debt
(2)
|
|
102,201
|
|
|
133
|
|
|
(46
|
)
|
|
102,288
|
|
||||
Asset-backed securities
|
|
24,268
|
|
|
47
|
|
|
(7
|
)
|
|
24,308
|
|
||||
Equity securities
|
|
14,985
|
|
|
2,210
|
|
|
—
|
|
|
17,195
|
|
||||
Total available-for-sale securities
|
|
$
|
258,123
|
|
|
$
|
2,860
|
|
|
$
|
(94
|
)
|
|
$
|
260,889
|
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
Corporate bonds
|
|
$
|
108,300
|
|
|
$
|
340
|
|
|
$
|
(69
|
)
|
|
$
|
108,571
|
|
U.S. government debt
(2)
|
|
106,335
|
|
|
60
|
|
|
(79
|
)
|
|
106,316
|
|
||||
Asset-backed securities
|
|
24,478
|
|
|
34
|
|
|
(11
|
)
|
|
24,501
|
|
||||
Total available-for-sale securities
|
|
$
|
239,113
|
|
|
$
|
434
|
|
|
$
|
(159
|
)
|
|
$
|
239,388
|
|
(1)
|
All unrealized loss positions were held at a loss for less than 12 months.
|
(2)
|
U.S. Treasury obligations, U.S. government agency obligations and U.S government agency mortgage-backed securities.
|
|
|
Three Months Ended March 31,
|
||
|
|
2014
|
||
Proceeds from sales and maturities of securities
|
|
$
|
30,119
|
|
Gross realized gains
|
|
13
|
|
|
Gross realized losses
|
|
(38
|
)
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
Trade customers
|
|
$
|
415,812
|
|
|
$
|
410,302
|
|
Affiliates
|
|
287
|
|
|
315
|
|
||
Allowance for doubtful accounts
|
|
(11,592
|
)
|
|
(11,741
|
)
|
||
|
|
404,507
|
|
|
398,876
|
|
||
Federal and state taxes
|
|
5,248
|
|
|
20,820
|
|
||
Other
|
|
12,124
|
|
|
8,761
|
|
||
Accounts receivable, net
|
|
$
|
421,879
|
|
|
$
|
428,457
|
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
Finished products
|
|
$
|
240,339
|
|
|
$
|
232,658
|
|
Feedstock, additives and chemicals
|
|
139,189
|
|
|
180,646
|
|
||
Materials and supplies
|
|
59,481
|
|
|
58,575
|
|
||
Inventories
|
|
$
|
439,009
|
|
|
$
|
471,879
|
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
3.60% senior notes due 2022
|
|
$
|
249,020
|
|
|
$
|
248,990
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
100,000
|
|
||
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
250,000
|
|
||
6 ½% senior notes due 2035 (the "6 ½% GO Zone Senior Notes Due 2035")
|
|
89,000
|
|
|
89,000
|
|
||
6 ½% senior notes due 2035 (the "6 ½% IKE Zone Senior Notes Due 2035")
|
|
65,000
|
|
|
65,000
|
|
||
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
||
Long-term debt, net
|
|
$
|
763,909
|
|
|
$
|
763,879
|
|
|
|
Derivative Assets
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
March 31,
2014 |
|
December 31,
2013 |
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accounts receivable, net
|
|
$
|
248
|
|
|
$
|
296
|
|
Total derivative assets
|
|
|
|
$
|
248
|
|
|
$
|
296
|
|
|
|
Derivative Liabilities
|
||||||||
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
March 31,
2014 |
|
December 31,
2013 |
||||||
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
Commodity forward contracts
|
|
Accrued liabilities
|
|
$
|
54
|
|
|
$
|
176
|
|
Total derivative liabilities
|
|
|
|
$
|
54
|
|
|
$
|
176
|
|
Derivatives in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in
Income on Derivative
|
|
Three Months Ended March 31,
|
||||||
2014
|
|
2013
|
||||||||
Commodity forward contracts
|
|
Cost of sales
|
|
$
|
—
|
|
|
$
|
(1,643
|
)
|
|
|
|
|
|
|
|
||||
Hedged Items in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in
Income on Hedged Items
|
|
Three Months Ended March 31,
|
||||||
2014
|
|
2013
|
||||||||
Firm commitment designated as the hedged item
|
|
Cost of sales
|
|
$
|
—
|
|
|
$
|
1,395
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss)
Recognized in
Income on Derivative
|
|
Three Months Ended March 31,
|
||||||
2014
|
|
2013
|
||||||||
Commodity forward contracts
|
|
Gross profit
|
|
$
|
(611
|
)
|
|
$
|
7,335
|
|
|
|
March 31, 2014
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets - Commodity forward contracts
|
|
$
|
—
|
|
|
$
|
248
|
|
|
$
|
248
|
|
Risk management liabilities - Commodity forward contracts
|
|
—
|
|
|
(54
|
)
|
|
(54
|
)
|
|||
Available-for-sale marketable securities
|
|
100,603
|
|
|
160,286
|
|
|
260,889
|
|
|||
|
|
|
|
|
|
|
||||||
|
|
December 31, 2013
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
Derivative instruments
|
|
|
|
|
|
|
||||||
Risk management assets - Commodity forward contracts
|
|
$
|
48
|
|
|
$
|
248
|
|
|
$
|
296
|
|
Risk management liabilities - Commodity forward contracts
|
|
—
|
|
|
(176
|
)
|
|
(176
|
)
|
|||
Available-for-sale marketable securities
|
|
91,595
|
|
|
147,793
|
|
|
239,388
|
|
|
|
March 31, 2014
|
|
December 31, 2013
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
3.60% senior notes due 2022
|
|
$
|
249,020
|
|
|
$
|
242,600
|
|
|
$
|
248,990
|
|
|
$
|
236,905
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
113,000
|
|
|
100,000
|
|
|
109,490
|
|
||||
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
281,775
|
|
|
250,000
|
|
|
265,148
|
|
||||
6 ½% GO Zone Senior Notes Due 2035
|
|
89,000
|
|
|
101,238
|
|
|
89,000
|
|
|
94,606
|
|
||||
6 ½% IKE Zone Senior Notes Due 2035
|
|
65,000
|
|
|
73,938
|
|
|
65,000
|
|
|
69,094
|
|
||||
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Net income
|
|
$
|
158,032
|
|
|
$
|
123,347
|
|
Less:
|
|
|
|
|
||||
Net income attributable to participating securities
|
|
(384
|
)
|
|
(568
|
)
|
||
Net income attributable to common shareholders
|
|
$
|
157,648
|
|
|
$
|
122,779
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Weighted average common shares—basic
(1)
|
|
133,072,254
|
|
|
133,251,071
|
|
||
Plus incremental shares from:
|
|
|
|
|
||||
Assumed exercise of options
(1)
|
|
540,670
|
|
|
566,666
|
|
||
Weighted average common shares—diluted
(1)
|
|
133,612,924
|
|
|
133,817,737
|
|
||
|
|
|
|
|
||||
Earnings per share:
(1)
|
|
|
|
|
||||
Basic
|
|
$
|
1.18
|
|
|
$
|
0.92
|
|
Diluted
|
|
$
|
1.18
|
|
|
$
|
0.92
|
|
(1)
|
Share amounts and per share data for the
three months ended March 31, 2013
have been restated to reflect the effect of a
two
-for-one stock split on March 18, 2014. See Note 1 for additional information.
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
|
Pension
|
|
Post-retirement
Healthcare
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Service cost
|
|
$
|
84
|
|
|
$
|
264
|
|
|
$
|
5
|
|
|
$
|
2
|
|
Interest cost
|
|
595
|
|
|
501
|
|
|
181
|
|
|
147
|
|
||||
Expected return on plan assets
|
|
(809
|
)
|
|
(714
|
)
|
|
—
|
|
|
—
|
|
||||
Amortization of prior service cost
|
|
74
|
|
|
74
|
|
|
13
|
|
|
21
|
|
||||
Amortization of net loss
|
|
63
|
|
|
429
|
|
|
69
|
|
|
90
|
|
||||
Net periodic benefit cost
|
|
$
|
7
|
|
|
$
|
554
|
|
|
$
|
268
|
|
|
$
|
260
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
Balances at December 31, 2013
|
|
$
|
(6,696
|
)
|
|
$
|
3,904
|
|
|
$
|
176
|
|
|
$
|
(2,616
|
)
|
Other comprehensive (loss) income before
reclassifications
|
|
—
|
|
|
(898
|
)
|
|
1,581
|
|
|
683
|
|
||||
Amounts reclassified from accumulated other
comprehensive loss
|
|
135
|
|
|
—
|
|
|
16
|
|
|
151
|
|
||||
Net other comprehensive income (loss) for the period
|
|
135
|
|
|
(898
|
)
|
|
1,597
|
|
|
834
|
|
||||
Balances at March 31, 2014
|
|
$
|
(6,561
|
)
|
|
$
|
3,006
|
|
|
$
|
1,773
|
|
|
$
|
(1,782
|
)
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Total
|
||||||
Balances at December 31, 2012
|
|
$
|
(16,351
|
)
|
|
$
|
5,511
|
|
|
$
|
(10,840
|
)
|
Other comprehensive loss before reclassifications
|
|
—
|
|
|
(570
|
)
|
|
(570
|
)
|
|||
Amounts reclassified from accumulated other comprehensive loss
|
|
378
|
|
|
—
|
|
|
378
|
|
|||
Net other comprehensive income (loss) for the period
|
|
378
|
|
|
(570
|
)
|
|
(192
|
)
|
|||
Balances at March 31, 2013
|
|
$
|
(15,973
|
)
|
|
$
|
4,941
|
|
|
$
|
(11,032
|
)
|
Details about Accumulated Other Comprehensive
Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Three Months Ended March 31,
|
||||||
|
2014
|
|
2013
|
|||||||
Amortization of pension and other post-retirement items
|
|
|
|
|
|
|
||||
Prior service costs
|
|
(1)
|
|
$
|
(87
|
)
|
|
$
|
(95
|
)
|
Net loss
|
|
(1)
|
|
(132
|
)
|
|
(519
|
)
|
||
|
|
|
|
(219
|
)
|
|
(614
|
)
|
||
|
|
Provision for income taxes
|
|
84
|
|
|
236
|
|
||
|
|
|
|
(135
|
)
|
|
(378
|
)
|
||
Net unrealized gains on available-for-sale investments
|
|
|
|
|
|
|
||||
Realized loss on available-for-sale investments
|
|
Other income, net
|
|
(25
|
)
|
|
—
|
|
||
|
|
Provision for income taxes
|
|
9
|
|
|
—
|
|
||
|
|
|
|
(16
|
)
|
|
—
|
|
||
Total reclassifications for the period
|
|
|
|
$
|
(151
|
)
|
|
$
|
(378
|
)
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, please read Note 10 (Employee Benefits) to the financial statements included in the
2013
Form 10-K.
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Net external sales
|
|
|
|
|
||||
Olefins
|
|
|
|
|
||||
Polyethylene
|
|
$
|
487,144
|
|
|
$
|
420,768
|
|
Styrene, feedstock and other
|
|
235,654
|
|
|
162,077
|
|
||
Total Olefins
|
|
722,798
|
|
|
582,845
|
|
||
Vinyls
|
|
|
|
|
||||
PVC, caustic soda and other
|
|
190,527
|
|
|
195,246
|
|
||
Building products
|
|
114,351
|
|
|
86,556
|
|
||
Total Vinyls
|
|
304,878
|
|
|
281,802
|
|
||
|
|
$
|
1,027,676
|
|
|
$
|
864,647
|
|
|
|
|
|
|
||||
Intersegment sales
|
|
|
|
|
||||
Olefins
|
|
$
|
56,853
|
|
|
$
|
70,283
|
|
Vinyls
|
|
343
|
|
|
264
|
|
||
|
|
$
|
57,196
|
|
|
$
|
70,547
|
|
|
|
|
|
|
||||
Income (loss) from operations
|
|
|
|
|
||||
Olefins
|
|
$
|
272,333
|
|
|
$
|
161,058
|
|
Vinyls
|
|
(21,114
|
)
|
|
43,663
|
|
||
Corporate and other
|
|
(3,164
|
)
|
|
(10,666
|
)
|
||
|
|
$
|
248,055
|
|
|
$
|
194,055
|
|
|
|
|
|
|
||||
Depreciation and amortization
|
|
|
|
|
||||
Olefins
|
|
$
|
26,647
|
|
|
$
|
23,346
|
|
Vinyls
|
|
19,168
|
|
|
11,884
|
|
||
Corporate and other
|
|
157
|
|
|
126
|
|
||
|
|
$
|
45,972
|
|
|
$
|
35,356
|
|
|
|
|
|
|
||||
Other income (expense), net
|
|
|
|
|
||||
Olefins
|
|
$
|
1,454
|
|
|
$
|
4,010
|
|
Vinyls
|
|
(34
|
)
|
|
(425
|
)
|
||
Corporate and other
|
|
1,089
|
|
|
(66
|
)
|
||
|
|
$
|
2,509
|
|
|
$
|
3,519
|
|
|
|
|
|
|
||||
Provision for (benefit from) income taxes
|
|
|
|
|
||||
Olefins
|
|
$
|
93,550
|
|
|
$
|
55,477
|
|
Vinyls
|
|
(10,070
|
)
|
|
13,720
|
|
||
Corporate and other
|
|
(105
|
)
|
|
(1,251
|
)
|
||
|
|
$
|
83,375
|
|
|
$
|
67,946
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Capital expenditures
|
|
|
|
|
||||
Olefins
|
|
$
|
29,074
|
|
|
$
|
50,040
|
|
Vinyls
|
|
81,120
|
|
|
100,317
|
|
||
Corporate and other
|
|
547
|
|
|
427
|
|
||
|
|
$
|
110,741
|
|
|
$
|
150,784
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Income from operations
|
|
$
|
248,055
|
|
|
$
|
194,055
|
|
Interest expense
|
|
(9,157
|
)
|
|
(6,281
|
)
|
||
Other income, net
|
|
2,509
|
|
|
3,519
|
|
||
Income before income taxes
|
|
$
|
241,407
|
|
|
$
|
191,293
|
|
|
|
March 31,
2014 |
|
December 31,
2013 |
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
1,556,856
|
|
|
$
|
1,557,510
|
|
Vinyls
|
|
1,768,572
|
|
|
1,740,595
|
|
||
Corporate and other
|
|
846,528
|
|
|
762,804
|
|
||
|
|
$
|
4,171,956
|
|
|
$
|
4,060,909
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
490,508
|
|
|
$
|
7,896
|
|
|
$
|
34,239
|
|
|
$
|
—
|
|
|
$
|
532,643
|
|
Marketable securities
|
|
243,694
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
243,694
|
|
|||||
Accounts receivable, net
|
|
58,050
|
|
|
888,829
|
|
|
3,381
|
|
|
(528,381
|
)
|
|
421,879
|
|
|||||
Inventories
|
|
—
|
|
|
422,166
|
|
|
16,843
|
|
|
—
|
|
|
439,009
|
|
|||||
Prepaid expenses and other
current assets
|
|
889
|
|
|
12,864
|
|
|
2,127
|
|
|
—
|
|
|
15,880
|
|
|||||
Deferred income taxes
|
|
441
|
|
|
33,422
|
|
|
295
|
|
|
—
|
|
|
34,158
|
|
|||||
Total current assets
|
|
793,582
|
|
|
1,365,177
|
|
|
56,885
|
|
|
(528,381
|
)
|
|
1,687,263
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
2,144,266
|
|
|
6,377
|
|
|
—
|
|
|
2,150,643
|
|
|||||
Equity investments
|
|
2,975,949
|
|
|
101,472
|
|
|
31,056
|
|
|
(3,040,917
|
)
|
|
67,560
|
|
|||||
Other assets, net
|
|
31,493
|
|
|
238,867
|
|
|
1,176
|
|
|
(5,046
|
)
|
|
266,490
|
|
|||||
Total assets
|
|
$
|
3,801,024
|
|
|
$
|
3,849,782
|
|
|
$
|
95,494
|
|
|
$
|
(3,574,344
|
)
|
|
$
|
4,171,956
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
463,650
|
|
|
$
|
193,020
|
|
|
$
|
14,351
|
|
|
$
|
(459,069
|
)
|
|
$
|
211,952
|
|
Accrued liabilities
|
|
15,782
|
|
|
200,781
|
|
|
731
|
|
|
(69,312
|
)
|
|
147,982
|
|
|||||
Total current liabilities
|
|
479,432
|
|
|
393,801
|
|
|
15,082
|
|
|
(528,381
|
)
|
|
359,934
|
|
|||||
Long-term debt
|
|
753,020
|
|
|
10,889
|
|
|
—
|
|
|
—
|
|
|
763,909
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
451,597
|
|
|
652
|
|
|
(5,046
|
)
|
|
447,203
|
|
|||||
Other liabilities
|
|
—
|
|
|
32,308
|
|
|
30
|
|
|
—
|
|
|
32,338
|
|
|||||
Stockholders' equity
|
|
2,568,572
|
|
|
2,961,187
|
|
|
79,730
|
|
|
(3,040,917
|
)
|
|
2,568,572
|
|
|||||
Total liabilities and
stockholders' equity |
|
$
|
3,801,024
|
|
|
$
|
3,849,782
|
|
|
$
|
95,494
|
|
|
$
|
(3,574,344
|
)
|
|
$
|
4,171,956
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
420,948
|
|
|
$
|
6,227
|
|
|
$
|
34,126
|
|
|
$
|
—
|
|
|
$
|
461,301
|
|
Marketable securities
|
|
239,388
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
239,388
|
|
|||||
Accounts receivable, net
|
|
3,879
|
|
|
738,156
|
|
|
2,755
|
|
|
(316,333
|
)
|
|
428,457
|
|
|||||
Inventories
|
|
—
|
|
|
456,306
|
|
|
15,573
|
|
|
—
|
|
|
471,879
|
|
|||||
Prepaid expenses and other
current assets
|
|
778
|
|
|
11,312
|
|
|
1,798
|
|
|
—
|
|
|
13,888
|
|
|||||
Deferred income taxes
|
|
441
|
|
|
33,422
|
|
|
306
|
|
|
—
|
|
|
34,169
|
|
|||||
Total current assets
|
|
665,434
|
|
|
1,245,423
|
|
|
54,558
|
|
|
(316,333
|
)
|
|
1,649,082
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
2,081,091
|
|
|
6,923
|
|
|
—
|
|
|
2,088,014
|
|
|||||
Equity investments
|
|
2,815,752
|
|
|
100,326
|
|
|
31,518
|
|
|
(2,880,721
|
)
|
|
66,875
|
|
|||||
Other assets, net
|
|
15,393
|
|
|
246,125
|
|
|
1,199
|
|
|
(5,779
|
)
|
|
256,938
|
|
|||||
Total assets
|
|
$
|
3,496,579
|
|
|
$
|
3,672,965
|
|
|
$
|
94,198
|
|
|
$
|
(3,202,833
|
)
|
|
$
|
4,060,909
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
316,652
|
|
|
$
|
223,134
|
|
|
$
|
10,649
|
|
|
$
|
(300,822
|
)
|
|
$
|
249,613
|
|
Accrued liabilities
|
|
8,334
|
|
|
161,140
|
|
|
1,282
|
|
|
(15,511
|
)
|
|
155,245
|
|
|||||
Total current liabilities
|
|
324,986
|
|
|
384,274
|
|
|
11,931
|
|
|
(316,333
|
)
|
|
404,858
|
|
|||||
Long-term debt
|
|
752,990
|
|
|
10,889
|
|
|
—
|
|
|
—
|
|
|
763,879
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
443,026
|
|
|
729
|
|
|
(5,779
|
)
|
|
437,976
|
|
|||||
Other liabilities
|
|
—
|
|
|
35,533
|
|
|
60
|
|
|
—
|
|
|
35,593
|
|
|||||
Stockholders' equity
|
|
2,418,603
|
|
|
2,799,243
|
|
|
81,478
|
|
|
(2,880,721
|
)
|
|
2,418,603
|
|
|||||
Total liabilities and
stockholders' equity |
|
$
|
3,496,579
|
|
|
$
|
3,672,965
|
|
|
$
|
94,198
|
|
|
$
|
(3,202,833
|
)
|
|
$
|
4,060,909
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
1,020,429
|
|
|
$
|
9,117
|
|
|
$
|
(1,870
|
)
|
|
$
|
1,027,676
|
|
Cost of sales
|
|
—
|
|
|
734,350
|
|
|
8,186
|
|
|
(1,870
|
)
|
|
740,666
|
|
|||||
Gross profit
|
|
—
|
|
|
286,079
|
|
|
931
|
|
|
—
|
|
|
287,010
|
|
|||||
Selling, general and administrative
expenses
|
|
546
|
|
|
37,063
|
|
|
1,346
|
|
|
—
|
|
|
38,955
|
|
|||||
(Loss) income from operations
|
|
(546
|
)
|
|
249,016
|
|
|
(415
|
)
|
|
—
|
|
|
248,055
|
|
|||||
Interest expense
|
|
(8,947
|
)
|
|
(210
|
)
|
|
—
|
|
|
—
|
|
|
(9,157
|
)
|
|||||
Other income (expense), net
|
|
5,006
|
|
|
(1,883
|
)
|
|
(614
|
)
|
|
—
|
|
|
2,509
|
|
|||||
(Loss) income before income taxes
|
|
(4,487
|
)
|
|
246,923
|
|
|
(1,029
|
)
|
|
—
|
|
|
241,407
|
|
|||||
(Benefit from) provision for income taxes
|
|
(1,558
|
)
|
|
85,110
|
|
|
(177
|
)
|
|
—
|
|
|
83,375
|
|
|||||
Equity in net income of subsidiaries
|
|
160,961
|
|
|
—
|
|
|
—
|
|
|
(160,961
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
$
|
158,032
|
|
|
$
|
161,813
|
|
|
$
|
(852
|
)
|
|
$
|
(160,961
|
)
|
|
$
|
158,032
|
|
Comprehensive income (loss)
|
|
$
|
158,866
|
|
|
$
|
161,948
|
|
|
$
|
(1,750
|
)
|
|
$
|
(160,198
|
)
|
|
$
|
158,866
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
856,085
|
|
|
$
|
10,540
|
|
|
$
|
(1,978
|
)
|
|
$
|
864,647
|
|
Cost of sales
|
|
—
|
|
|
629,286
|
|
|
9,530
|
|
|
(1,978
|
)
|
|
636,838
|
|
|||||
Gross profit
|
|
—
|
|
|
226,799
|
|
|
1,010
|
|
|
—
|
|
|
227,809
|
|
|||||
Selling, general and administrative
expenses
|
|
510
|
|
|
31,709
|
|
|
1,535
|
|
|
—
|
|
|
33,754
|
|
|||||
(Loss) income from operations
|
|
(510
|
)
|
|
195,090
|
|
|
(525
|
)
|
|
—
|
|
|
194,055
|
|
|||||
Interest expense
|
|
(6,258
|
)
|
|
(23
|
)
|
|
—
|
|
|
—
|
|
|
(6,281
|
)
|
|||||
Other income (expense), net
|
|
4,309
|
|
|
(290
|
)
|
|
(500
|
)
|
|
—
|
|
|
3,519
|
|
|||||
(Loss) income before income taxes
|
|
(2,459
|
)
|
|
194,777
|
|
|
(1,025
|
)
|
|
—
|
|
|
191,293
|
|
|||||
(Benefit from) provision for income taxes
|
|
(874
|
)
|
|
69,051
|
|
|
(231
|
)
|
|
—
|
|
|
67,946
|
|
|||||
Equity in net income of subsidiaries
|
|
124,932
|
|
|
—
|
|
|
—
|
|
|
(124,932
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
$
|
123,347
|
|
|
$
|
125,726
|
|
|
$
|
(794
|
)
|
|
$
|
(124,932
|
)
|
|
$
|
123,347
|
|
Comprehensive income (loss)
|
|
$
|
123,155
|
|
|
$
|
126,104
|
|
|
$
|
(1,364
|
)
|
|
$
|
(124,740
|
)
|
|
$
|
123,155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
158,032
|
|
|
$
|
161,813
|
|
|
$
|
(852
|
)
|
|
$
|
(160,961
|
)
|
|
$
|
158,032
|
|
Adjustments to reconcile net income
(loss) to net cash (used for) provided
by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
365
|
|
|
45,408
|
|
|
564
|
|
|
—
|
|
|
46,337
|
|
|||||
Deferred income taxes
|
|
(162
|
)
|
|
8,487
|
|
|
(50
|
)
|
|
—
|
|
|
8,275
|
|
|||||
Net changes in working capital
and other
|
|
(165,553
|
)
|
|
6,263
|
|
|
(1,810
|
)
|
|
160,961
|
|
|
(139
|
)
|
|||||
Net cash (used for) provided by
operating activities
|
|
(7,318
|
)
|
|
221,971
|
|
|
(2,148
|
)
|
|
—
|
|
|
212,505
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and
equipment
|
|
—
|
|
|
(110,559
|
)
|
|
(182
|
)
|
|
—
|
|
|
(110,741
|
)
|
|||||
Proceeds from disposition of assets
|
|
—
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|||||
Proceeds from sales and maturities of
securities
|
|
30,119
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30,119
|
|
|||||
Purchase of securities
|
|
(49,025
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(49,025
|
)
|
|||||
Settlements of derivative instruments
|
|
—
|
|
|
(409
|
)
|
|
—
|
|
|
—
|
|
|
(409
|
)
|
|||||
Net cash used for investing
activities
|
|
(18,906
|
)
|
|
(110,956
|
)
|
|
(182
|
)
|
|
—
|
|
|
(130,044
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
106,903
|
|
|
(109,346
|
)
|
|
2,443
|
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(16,789
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,789
|
)
|
|||||
Proceeds from exercise of stock options
|
|
2,158
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,158
|
|
|||||
Windfall tax benefits from share-based
payment arrangements
|
|
3,512
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,512
|
|
|||||
Net cash provided by (used for)
financing activities
|
|
95,784
|
|
|
(109,346
|
)
|
|
2,443
|
|
|
—
|
|
|
(11,119
|
)
|
|||||
Net increase in cash and cash equivalents
|
|
69,560
|
|
|
1,669
|
|
|
113
|
|
|
—
|
|
|
71,342
|
|
|||||
Cash and cash equivalents at beginning
of period
|
|
420,948
|
|
|
6,227
|
|
|
34,126
|
|
|
—
|
|
|
461,301
|
|
|||||
Cash and cash equivalents at end of period
|
|
$
|
490,508
|
|
|
$
|
7,896
|
|
|
$
|
34,239
|
|
|
$
|
—
|
|
|
$
|
532,643
|
|
|
|
Westlake
Chemical
Corporation
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
123,347
|
|
|
$
|
125,726
|
|
|
$
|
(794
|
)
|
|
$
|
(124,932
|
)
|
|
$
|
123,347
|
|
Adjustments to reconcile net income
(loss) to net cash (used for) provided
by operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
365
|
|
|
34,766
|
|
|
590
|
|
|
—
|
|
|
35,721
|
|
|||||
Deferred income taxes
|
|
(23
|
)
|
|
29,896
|
|
|
(407
|
)
|
|
—
|
|
|
29,466
|
|
|||||
Net changes in working capital
and other
|
|
(129,403
|
)
|
|
(68,474
|
)
|
|
663
|
|
|
124,932
|
|
|
(72,282
|
)
|
|||||
Net cash (used for) provided by
operating activities
|
|
(5,714
|
)
|
|
121,914
|
|
|
52
|
|
|
—
|
|
|
116,252
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and
equipment
|
|
—
|
|
|
(149,113
|
)
|
|
(1,671
|
)
|
|
—
|
|
|
(150,784
|
)
|
|||||
Proceeds from disposition of assets
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
2
|
|
|||||
Proceeds from repayment of loan
to affiliate
|
|
—
|
|
|
—
|
|
|
167
|
|
|
—
|
|
|
167
|
|
|||||
Proceeds from sales and maturities of
securities
|
|
124,873
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
124,873
|
|
|||||
Purchase of securities
|
|
(94,903
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(94,903
|
)
|
|||||
Settlements of derivative instruments
|
|
—
|
|
|
(679
|
)
|
|
—
|
|
|
—
|
|
|
(679
|
)
|
|||||
Net cash provided by (used for)
investing activities
|
|
29,970
|
|
|
(149,792
|
)
|
|
(1,502
|
)
|
|
—
|
|
|
(121,324
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
(28,120
|
)
|
|
28,553
|
|
|
(433
|
)
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(12,553
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,553
|
)
|
|||||
Proceeds from exercise of stock options
|
|
1,590
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,590
|
|
|||||
Windfall tax benefits from share-based
payment arrangements
|
|
3,844
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,844
|
|
|||||
Net cash (used for) provided by
financing activities
|
|
(35,239
|
)
|
|
28,553
|
|
|
(433
|
)
|
|
—
|
|
|
(7,119
|
)
|
|||||
Net (decrease) increase in cash and
cash equivalents
|
|
(10,983
|
)
|
|
675
|
|
|
(1,883
|
)
|
|
—
|
|
|
(12,191
|
)
|
|||||
Cash and cash equivalents at beginning
of period
|
|
753,881
|
|
|
6,973
|
|
|
29,224
|
|
|
—
|
|
|
790,078
|
|
|||||
Cash and cash equivalents at end of period
|
|
$
|
742,898
|
|
|
$
|
7,648
|
|
|
$
|
27,341
|
|
|
$
|
—
|
|
|
$
|
777,887
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(dollars in thousands,
except per share data)
|
||||||
Net external sales
|
|
|
|
|
||||
Olefins
|
|
|
|
|
||||
Polyethylene
|
|
$
|
487,144
|
|
|
$
|
420,768
|
|
Styrene, feedstock and other
|
|
235,654
|
|
|
162,077
|
|
||
Total Olefins
|
|
722,798
|
|
|
582,845
|
|
||
Vinyls
|
|
|
|
|
||||
PVC, caustic soda and other
|
|
190,527
|
|
|
195,246
|
|
||
Building products
|
|
114,351
|
|
|
86,556
|
|
||
Total Vinyls
|
|
304,878
|
|
|
281,802
|
|
||
Total
|
|
$
|
1,027,676
|
|
|
$
|
864,647
|
|
|
|
|
|
|
||||
Income (loss) from operations
|
|
|
|
|
||||
Olefins
|
|
$
|
272,333
|
|
|
$
|
161,058
|
|
Vinyls
|
|
(21,114
|
)
|
|
43,663
|
|
||
Corporate and other
|
|
(3,164
|
)
|
|
(10,666
|
)
|
||
Total income from operations
|
|
248,055
|
|
|
194,055
|
|
||
Interest expense
|
|
(9,157
|
)
|
|
(6,281
|
)
|
||
Other income, net
|
|
2,509
|
|
|
3,519
|
|
||
Provision for income taxes
|
|
83,375
|
|
|
67,946
|
|
||
Net income
|
|
$
|
158,032
|
|
|
$
|
123,347
|
|
Diluted earnings per share
(1)
|
|
$
|
1.18
|
|
|
$
|
0.92
|
|
_____________
|
|
|
|
|
||||
(1) Per share data for the three months ended March 31, 2013 has been restated to reflect the effect of a two-for-one
stock split on March 18, 2014. See Note 1 to the unaudited consolidated financial statements within this Quarterly
Report on Form 10-Q for additional information.
|
||||||||
|
|
|
|
|
||||
|
|
Three Months Ended March 31, 2014
|
||||||
|
|
Average
Sales Price
|
|
Volume
|
||||
Product sales price and volume percentage change from prior year period
|
|
|
|
|
||||
Olefins
|
|
+13.3
|
%
|
|
+10.7
|
%
|
||
Vinyls
|
|
+1.7
|
%
|
|
+4.9
|
%
|
||
Company average
|
|
+9.5
|
%
|
|
+8.8
|
%
|
||
|
|
|
|
|
||||
|
|
Three Months Ended March 31,
|
||||||
|
|
2014
|
|
2013
|
||||
Average industry prices
(1)
|
|
|
|
|
||||
Ethane (cents/lb)
|
|
11.4
|
|
|
8.7
|
|
||
Propane (cents/lb)
|
|
30.8
|
|
|
20.5
|
|
||
Ethylene (cents/lb)
(2)
|
|
55.1
|
|
|
63.3
|
|
||
Polyethylene (cents/lb)
(3)
|
|
107.7
|
|
|
97.3
|
|
||
Styrene (cents/lb)
(4)
|
|
86.9
|
|
|
85.9
|
|
||
Caustic soda ($/short ton)
(5)
|
|
579.2
|
|
|
602.5
|
|
||
Chlorine ($/short ton)
(6)
|
|
236.7
|
|
|
255.0
|
|
||
PVC (cents/lb)
(7)
|
|
66.5
|
|
|
59.2
|
|
(1)
|
Industry pricing data was obtained from IHS Chemical. We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
(3)
|
Represents average North American contract prices of polyethylene low density film over the period as reported by IHS Chemical.
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS Chemical.
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS Chemical.
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS Chemical.
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS Chemical.
|
•
|
future operating rates, margins, cash flow and demand for our products;
|
•
|
industry market outlook;
|
•
|
production capacities;
|
•
|
our ability to borrow additional funds under our credit facility;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industry;
|
•
|
timing, funding and results of the expansion programs at our Lake Charles and Calvert City complexes;
|
•
|
results of the new chlor-alkali plant in Geismar;
|
•
|
results of the feedstock conversion program at our Calvert City ethylene plant;
|
•
|
health of our customer base;
|
•
|
pension plan funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other greenhouse gases emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States and worldwide economies, including those due to political tensions in the Middle East and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and regulatory actions and political unrest in other countries;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations;
|
•
|
technological developments;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period
|
|
Total Number
of Shares
Purchased
(1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(2)
|
||||||
January 2014
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
53,780,000
|
|
February 2014
|
|
24,723
|
|
|
$
|
129.13
|
|
|
—
|
|
|
$
|
53,780,000
|
|
March 2014
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
53,780,000
|
|
|
|
24,723
|
|
|
$
|
129.13
|
|
|
—
|
|
|
|
(1)
|
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock and restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
On August 22, 2011, we announced the authorization by our Board of Directors of a $100.0 million stock repurchase program. As of
March 31, 2014
,
1,252,922
shares of common stock (on a post-split basis) had been acquired at an aggregate purchase price of
$46.2 million
. Decisions regarding the amount and the timing of purchases under the program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The program may be discontinued by our Board of Directors at any time. None of the purchases during the
first quarter of 2014
were pursuant to this program.
|
Item 6.
|
Exhibits
|
Exhibit No.
|
|
|
|
|
|
31.1
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Executive Officer)
|
|
|
|
31.2
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Financial Officer)
|
|
|
|
32.1
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer)
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
||
|
|
|
|
|||
Date:
|
May 6, 2014
|
|
|
By:
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|||
Date:
|
May 6, 2014
|
|
|
By:
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer
and Treasurer
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|